Call for Scientific Papers
AOECS is now welcoming submissions for the 4th edition of our Call for Scientific Posters, focusing on research and innovation related to coeliac disease. Approved abstracts will be presented at the AOECS Annual Conference in Brussels on 17–18 October 2025 and published in our scientific book.
New this year: a dedicated call for papers on gluten-free beer.
News
See all news here
- 21st July 2025
- 1 min read
AOECS launches a global call for success stories from National Coeliac Societies, both members and non-members to be included in AOECS's first Global Success Stories Book 2025.
- 14th July 2025
- 1 min read
Susana Tavares and Veronica Rubio from AOECS will join discussions in Berlin on 5 October, bringing the coeliac patient perspective to Europe’s largest digestive health event, gathering 11,000 participants from 115 countries. We’re proud to help shape the agenda on patient involvement, clinical trials, and digestive cancer care.
- 6th June 2025
- 2 min read
AOECS invites submissions for its 4th Call for Scientific Papers on Coeliac Disease – now with a special focus on hydrolysed products such as gluten-free beer. Don't miss the opportunity to present your work on a global stage. Submit your abstract by 5 September 2025.
What we do
Firstly, we care.
We strive for the best possible safety, availability and consistent labelling of foods and products suitable for people intolerant to gluten.
The resources you need.
We coordinate the exchange of information related coeliac disease, encouraging skill and knowledge sharing, particularly among new and developing Coeliac Societies.
Supporting our members
We represent our members at an international level, particularly with respect to European legislation, policy development and fostering multi-national research projects.
Gluten Free Certification
The Crossed Grain Trademark is widely recognised as a source of trust and reassurance that a product is safe to eat. Our Europe wide licensing system means that one trademark license gives producers and retailers the right to use the Crossed Grain Trademark on their gluten free sales in over 30 European countries.
Find out moreAbout coeliac disease
1 in 100 people are estimated to suffer from coeliac disease in Europe. Applying that ratio, it can be assumed that more than 7 million people are affected by coeliac disease across Europe, with only approximately 25% of those actually receiving a diagnosis. Coeliac disease can present with a wide range of mild to very severe symptoms with the only treatment being a strict daily gluten free diet.
Read moreCurious about what coeliac disease is? Watch this short film that explains the facts.
The film was created as a part of the international collaboration Focus IN CD.